THE FIRST EXPERIENCE OF ESTIMATION OF MOTOR PATHWAYS AND CENTRAL INHIBITION IN PATIENTS WITH BRAIN MALIGNANT GLIOMAS AT PREPARATION FOR CONFORMAL RADIATION THERAPY
Vol. 70 No. 2 (2024), Articles
Vol. 70 No. 2 (2024)

THE FIRST EXPERIENCE OF ESTIMATION OF MOTOR PATHWAYS AND CENTRAL INHIBITION IN PATIENTS WITH BRAIN MALIGNANT GLIOMAS AT PREPARATION FOR CONFORMAL RADIATION THERAPY

Articles
https://doi.org/10.37469/0507-3758-2013-59-4-487-490
Published 15.12.2013
Russian Research Center of Radiology and Surgical Technologies
Russian Research Center of Radiology and Surgical Technologies
Research Institute for Childhood Infections of the Federal Medical and Biological Agency
##article.numberofdownloads## 17
##article.numberofviews## 50
PDF (Русский)

Keywords

glioma
transcranial magnetic stimulation
silent period
caused motor response

How to Cite

, , & . (2013). THE FIRST EXPERIENCE OF ESTIMATION OF MOTOR PATHWAYS AND CENTRAL INHIBITION IN PATIENTS WITH BRAIN MALIGNANT GLIOMAS AT PREPARATION FOR CONFORMAL RADIATION THERAPY. Voprosy Onkologii, 70(2), 487–490. https://doi.org/10.37469/0507-3758-2013-59-4-487-490
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

We investigated central motor pathways and central inhibition in patients with brain gliomas by transcranial magnetic stimulation (TMS). 10 glioma patients and 16 matching controls were enrolled. Central motor conduction time, MEP latencies and amplitudes and silent period were evaluated. In 90% glioma patients TMS parameters were abnormal, mostly MEP shapes and thresholds were affected. In 40% of the cases central inhibition in glioma affected hemisphere was abnormally high. We propose that TMS is safe and informative tool in glioma patients; central inhibition seems to be affected in some cases by the glioma presence in the hemisphere. One of the possible causes of that may be GABA system activation.
https://doi.org/10.37469/0507-3758-2013-59-4-487-490
##article.numberofdownloads## 17
##article.numberofviews## 50
PDF (Русский)

References

Войтенков В.Б., Киселева Л.Н., Карташев А.В. Диагностическая транскраниальная магнитная стимуляция при новообразованиях головного мозга // Сибир. онкол. журн. —2012. — № 5. — С. 85-89.

Войтенков В.Б., Киселева Л.Н., Карташев А.В. Исследование влияния дельта-сон индуцирующего пептида на процессы центрального торможения у человека // Врач-аспирант. — 2012. — № 3. — С. 290-294.

Гимранов Р.Ф., Курдюкова Е.Н. Оценка состояния пирамидной системы у пациентов с опухолями ствола головного мозга // Вопр. нейрох. — 2003. — № 1. — С. 32-35.

Девойно Л.В., Идова Г.В., Альперина Е.Л. и пр. Системные мозговые механизмы нейроиммуномодуляции: психоэмоциональный вклад // Бюл. Сибир. отделения РАМН. — 2004. — № 2. — С. 90-97.

Кривопуск М.Е. Аммиак, глютаминовая кислота, глютамин и γ-аминомасляная кислота в люмбальной и желудочковой жидкости больных с опухолями центральной нервной системы // Вопр. мед. химии. — 1965. — Т. 11. — В. 5. — С. 59-62.

Никитин С. С., Куренков А.Л. Магнитная стимуляция в диагностике и лечении болезней нервной системы. М.: САШКО, 2003. — 378 с.

Сытинский И.А., Чайка Т.В., Бернштам В.А. γ-аминомасляная кислота и глютаматдекарбоксилаза в опухолях головного мозга человека // Вопросы медицинской химии. — 1968. — Т. 14. — С. 434-436.

Al-Wadei H.A., Al-Wadei M.H., Ullah M.F., Schuller H.M. Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice // PLoS One. — 2012. — Vol. 7. — P. 433-446.

Brasil-Neto J.P., Cammarota A., Valls-Sole J., Pascual-Leone A. et al. Role of intracortical mechanisms in the late part of the silent period to transcranial stimulation of the human motor cortex // Acta Neurologica Scandinavica. — 1995. — Vol. 92. — P. 383-386.

Heffner K.L., Loving T.J., Robles T.F. et al. Examining psychosocial factors related to cancer incidence and progression: In search of the silver lining // Brain Behav Immun. — 2003. — Vol. 17. — P. 109-111.

Israël M. A possible primary cause of cancer: deficient cellular interactions in endocrine pancreas // Mol. Cancer. — 2012. — Vol.11. — P. 63-70.

Ohgaki H., Kleihues P. Epidemiology and etiology of gliomas // Acta Neuropathol. — 2005. — Vol. 109. — P. 93-108.

Sale M.V., Ridding M.C., Nordstrom M.A. Cortisol inhibits neuroplasticity in human motor cortex // The Journal of Neuroscience. — 2008. — Vol. 28. — P. 8285-8293.

Sale M.V., Ridding M.C., Nordstrom M.A. Factors influencing the magnitude and reproducibility of corticomo-tor excitability changes induced by paired associative stimulation // Exp. Brain Res. — 2007. — Vol. 181. — P. 615-626.

Schmidt D., Loscher W. Plasma and cerebrospinal fluid v-aminobutyric acid in neurological disorders // J. Neurol., Neurosurg., and Psychiat. — 1982. — Vol. 45. — P. 931-935.

Smits A., Jin Z., Elsir T. et al. GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome // PLoS One. — 2012. — Vol. 7. — P. 1-10.

Takano, T. et al. Glutamate release promotes growth of malignant gliomas // Nat. Med. — 2001. — Vol. 7. — P. 1010-1015.

Watkins S., Sontheimer H. Unique biology of gliomas: challenges and opportunities // Trends in Neurosciences. — 2012. — Vol. 35. — P. 546-556.

Werhahn K.J., Kunesh E., Noachtar S. et al. Differential effects on motocortical inhibition induced by blockade of GABA uptake in humans// J. Physiol. — 1999. — Vol. 517. — P. 591-597.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...